Therapeutic potential of silymarin as a natural iron-chelating agent in β-thalassemia intermedia. - GreenMedInfo Summary
Therapeutic potential of silymarin as a natural iron-chelating agent inβ-thalassemia intermedia.
Clin Case Rep. 2022 Jan ;10(1):e05293. Epub 2022 Jan 24. PMID: 35106163
Nahid Reisi
Abnormal iron accumulation in vital organs is one of the major complications ofβ-thalassemia intermedia (β-TI). Silymarin, a flavonolignan isolated from, significantly decreases the serum ferritin levels ofβ-TI patients. This finding suggests silymarin as a safe and effective natural iron-chelating agent for the treatment of iron-overloaded conditions.